Search
MoonLake Immunotherapeutics
MLTXAdd to Watchlist
12.500USD
-0.370-2.87%
Close 11-13 16:00（ET）
1.06BMarket Cap
LossP/E TTM
Today
-2.87%
5 Days
+8.41%
1 Month
+23.27%
6 Months
-32.03%
Year to Date
-5.16%
1 Year
-2.11%
Key Figures
12.860Open
13.470High
99.10KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.12%Turnover Ratio
12.870Prev. Close
12.390Low
1.25MTurnover
LossP/E Static
2.78P/B
0.00%Div Yield TTM
-56.92%ROA
23.29052wk High
0.07Volume Ratio
-118.94MNet Profit
85.11MShares
-3.8726EPS TTM
1.02Beta
-77.72%ROE
9.46052wk Low
8.39%Amplitude
--Gross Margin
1.06BMarket Cap
-3.28Reward/Risk
4.67%Risk Rate
More news coming soon, stay tuned...
Analyst Rating
MoonLake Immunotherapeutics Technical Analysis
Technical Indicators
Neutral
Summary
Neutral
Moving Average
Neutral
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
-0.93/-0.78
Revenue / Forecast
--/0.00
MoonLake Immunotherapeutics Profile
SectorBiotechnology & Medical Research
Ticker SymbolMLTX
Number of employees100
CountrySwitzerland
Ownership
| Shareholders | Proportion |
|---|---|
| BVF Partners L.P. | 21.74% |
| Deep Track Capital LP | 6.26% |
| Cormorant Asset Management, LP | 5.92% |
| Reich (Kristian) | 4.09% |
| Shareholder Types | Proportion |
|---|---|
| Hedge Fund | 49.10% |
| Individual Investor | 9.97% |
| Investment Advisor | 8.58% |
| Research Firm | 6.25% |
Related Instruments
+1.26%
+0.79%
+0.20%
+0.55%
+0.16%
+0.04%
-0.30%
+0.08%
+2.41%
+0.21%
-0.74%
+1.78%
+2.39%
-0.19%
+0.52%
+0.45%
-3.45%
+1.47%
+1.06%
-2.17%
FAQs
What is the current price of MoonLake Immunotherapeutics (MLTX)?
The current price of MoonLake Immunotherapeutics (MLTX) is 12.50.
What is the symbol of MoonLake Immunotherapeutics?
The ticker symbol of MoonLake Immunotherapeutics is MLTX.
What is the 52-week high of MoonLake Immunotherapeutics?
The 52-week high of MoonLake Immunotherapeutics is 23.29.
What is the 52-week low of MoonLake Immunotherapeutics?
The 52-week low of MoonLake Immunotherapeutics is 9.46.
What is the market capitalization of MoonLake Immunotherapeutics?
The market capitalization of MoonLake Immunotherapeutics is 1.06B.
Is MoonLake Immunotherapeutics (MLTX) currently rated as Buy, Hold, or Sell?
According to analysts, MoonLake Immunotherapeutics (MLTX) has an overall rating of Buy, with a price target of 31.50.
What is the Earnings Per Share (EPS TTM) of MoonLake Immunotherapeutics (MLTX)?
The Earnings Per Share (EPS TTM) of MoonLake Immunotherapeutics (MLTX) is -3.87.